Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Adenoviral Human p53 Gene

p53 gene therapy · Shenzhen SiBiono GeneTech Co.,Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Adenoviral Human p53 Gene, covering 2015-04-29 to 2015-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion [Phase 2]

See pricing